The psychopharmacology of European herbs with cognition-enhancing properties

Human Cognitive Neuroscience Unit, Division of Psychology, Northumbria University, Newcastle upon Tyne, NE1 8ST UK.
Current pharmaceutical design (Impact Factor: 3.29). 02/2006; 12(35):4613-23. DOI: 10.2174/138161206779010387
Source: PubMed

ABSTRACT Extensive research suggests that a number of plant-derived chemicals and traditional Oriental herbal remedies possess cognition-enhancing properties. Widely used current treatments for dementia include extracts of Ginkgo biloba and several alkaloidal, and therefore toxic, plant-derived cholinergic agents. Several non-toxic, European herbal species have pan-cultural traditions as treatments for cognitive deficits, including those associated with ageing. To date they have not received research interest commensurate with their potential utility. Particularly promising candidate species include sage (Salvia lavandulaefolia/officinalis), Lemon balm (Melissa officinalis) and rosemary (Rosmarinus officinalis). In the case of sage, extracts possess anti-oxidant, estrogenic, and anti-inflammatory properties, and specifically inhibit butyryl- and acetyl-cholinesterase. Acute administration has also been found to reliably improve mnemonic performance in healthy young and elderly cohorts, whilst a chronic regime has been shown to attenuate cognitive declines in sufferers from Alzheimer's disease. In the case of Melissa officinalis, extracts have, most notably, been shown to bind directly to both nicotinic and muscarinic receptors in human brain tissue. This property has been shown to vary with extraction method and strain. Robust anxiolytic effects have also been demonstrated following acute administration to healthy humans, with mnemonic enhancement restricted to an extract with high cholinergic binding properties. Chronic regimes of aromatherapy and essential oil respectively have also been shown to reduce agitation and attenuate cognitive declines in sufferers from dementia. Given the side effect profile of prescribed cholinesterase inhibitors, and a current lack of a well tolerated nicotinic receptor agonist, these herbal treatments may well provide effective and well-tolerated treatments for dementia, either alone, in combination, or as an adjunct to conventional treatments.

Download full-text


Available from: Andrew Scholey, Jul 05, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Aim of the study: In southern India, ayurvedic practitioners traditionally employ the whole herb of Canscora decussata Schult. (CD) (Gentianaceae) as a traditional ayruvedic medicine, Shankhpushpi for its memory potentiating, anxiolytic and tranquilizing properties. The present study investigated the effect of CD, which is regarded as Shankhpushpi, for its effects on learning and memory in rodents. The extract was further studied for its in vitro acetylcholinesterase (AChE) inhibitory potential which can correlate with its cognition boosting effect. Materials and methods: Ethanol extract of CD was analyzed by high performance thin layer chromatography (HPTLC) and high performance liquid chromatography (HPLC). Ethanol extract of CD was investigated for its AChE enzyme inhibitory activity. Nootropic activity using Elevated plus maze apparatus, passive avoidance (Cook and Weidley’s pole climbing, step down) paradigms and active avoidance (two compartment shuttle box) test were used to learning and memory. Results: HPTLC and HPLC fingerprinting of ethanol extract revealed presence of mangiferin as its main constituent. It was found that CD potentially inhibits AChE with 50% inhibitory concentration (IC50) of 165.667 ± 0.213 mg/ml. It was found that groups (n = 6), receiving ethanol extract in doses of 200 and 400 mg/kg p.o. significantly reversed the amnesia induced by scopolamine (0.3 mg/kg i.p.). Nootropic activity was compared using piracetam (100 mg/kg p.o.) as the standard. Conclusion: Ethanol extract of CD showed significant effects on learning behavior and memory enhancement as evidenced from the experiments performed. The activity may be attributed to the presence of various xanthones and mangiferin, a polyphenolic xanthone.
    European Journal of Integrative Medicine 03/2012; 4(1):e113-e121. DOI:10.1016/j.eujim.2011.11.003
  • Source
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Extracts of Melissa officinalis (Lemon Balm) are extensively used in traditional medicines. This study examined the anticonvulsant activity of the hydroalcoholic extract of M. officinalis on pentylenetetrazole (PTZ)-induced seizures threshold in mice. The fresh leaves and the whole plant of M. officinalis were used by a routine method to produce an injectable solution for administration. M. officinalis and normal Saline were injected intraperitoneally (IP) at the doses 100, 300, 600 and 900 and 1200 mg/kg, i.p and 10 ml/kg i.p, respectively, 30 min before the administration of PTZ (90 mg/kg, i.p). For measurement of anticonvulsant activity of animals, convulsive symptoms were divided into 3 level (scores 1-3) which were C 1 , C 2 and C 3 . The time taken before C 1 , C 2 and C 3 and the percentage of seizure and mortality protection rate were recorded. Statistical analyses of all treatment and control groups show that M. officinalis significantly can increases onset time of convulsive symptoms in all 3 levels of seizure in the PTZ model. On the other hand, onset time of convulsive symptoms increases by doses increasing which may indicate the dose-dependent effect of M. officinalis. It seems that it can be useful for treatment of seizure.

Similar Publications